Antisense oligonucleotide therapeutics

This publication has 97 references indexed in Scilit:

• Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 Mice
  Antisense and Nucleic Acid Drug Development, 1997
• Protein Kinase C-ζ Mediates Angiotensin II Activation of ERK1/2 in Vascular Smooth Muscle Cells
  Published by Elsevier ,1997
• Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications
  Nucleic Acids Research, 1996
• Pharmacokinetics of Antisense Oligonucleotides
  Clinical Pharmacokinetics, 1995
• Oligonucleotides in the treatment of leukemia
  Hematological Oncology, 1994
• Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus
  Life Sciences, 1994
• Stimulation ofin vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides
  Molecular Biology Reports, 1993
• Antisense oligonucleotides made of 2'‐O‐alkylRNA: their properties and applications in RNA biochemistry
  FEBS Letters, 1993
• Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?
  Pharmacology & Therapeutics, 1991
• Sequence‐dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H
  FEBS Letters, 1987